Research, discovery, and translation to practice are at the core of the mission for the George Washington University School of Medicine and Health Sciences. By accelerating research excellence, enhancing innovation, and advancing translation, our goal is to make discoveries and improve clinical care.
The scientific workforce, composed of highly educated researchers and scientists-in training, clinician investigators, as well as skilled technical support staff, project managers, and core team members, together contribute to research discovery. Training the next generation of biomedical scientists is a key goal.
Funding and support, obtained from federal and non-federal grants and contracts, private industry investment, and philanthropy, is essential to sustain our research programs. SMHS provides funding opportunities and strategies to gain support.
A joint group of researchers at the George Washington University and the University of Pittsburgh have found that dopamine and the dopamine D2 receptor modulate expression via the Wnt/β-catenin signaling pathway. This pathway is responsible for control of cell proliferation and organ identity and is implicated in cancer, thus having broad implications for health and development of new therapeutics